479 related articles for article (PubMed ID: 27480342)
1. Microcarrier-based platforms for in vitro expansion and differentiation of human pluripotent stem cells in bioreactor culture systems.
Badenes SM; Fernandes TG; Rodrigues CAV; Diogo MM; Cabral JMS
J Biotechnol; 2016 Sep; 234():71-82. PubMed ID: 27480342
[TBL] [Abstract][Full Text] [Related]
2. Facile engineering of xeno-free microcarriers for the scalable cultivation of human pluripotent stem cells in stirred suspension.
Fan Y; Hsiung M; Cheng C; Tzanakakis ES
Tissue Eng Part A; 2014 Feb; 20(3-4):588-99. PubMed ID: 24098972
[TBL] [Abstract][Full Text] [Related]
3. Superior Red Blood Cell Generation from Human Pluripotent Stem Cells Through a Novel Microcarrier-Based Embryoid Body Platform.
Sivalingam J; Lam AT; Chen HY; Yang BX; Chen AK; Reuveny S; Loh YH; Oh SK
Tissue Eng Part C Methods; 2016 Aug; 22(8):765-80. PubMed ID: 27392822
[TBL] [Abstract][Full Text] [Related]
4. Impact of Feeding Strategies on the Scalable Expansion of Human Pluripotent Stem Cells in Single-Use Stirred Tank Bioreactors.
Kropp C; Kempf H; Halloin C; Robles-Diaz D; Franke A; Scheper T; Kinast K; Knorpp T; Joos TO; Haverich A; Martin U; Zweigerdt R; Olmer R
Stem Cells Transl Med; 2016 Oct; 5(10):1289-1301. PubMed ID: 27369897
[TBL] [Abstract][Full Text] [Related]
5. An integrated biomanufacturing platform for the large-scale expansion and neuronal differentiation of human pluripotent stem cell-derived neural progenitor cells.
Srinivasan G; Morgan D; Varun D; Brookhouser N; Brafman DA
Acta Biomater; 2018 Jul; 74():168-179. PubMed ID: 29775730
[TBL] [Abstract][Full Text] [Related]
6. Considerations in designing systems for large scale production of human cardiomyocytes from pluripotent stem cells.
Chen A; Ting S; Seow J; Reuveny S; Oh S
Stem Cell Res Ther; 2014 Jan; 5(1):12. PubMed ID: 24444355
[TBL] [Abstract][Full Text] [Related]
7. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
[TBL] [Abstract][Full Text] [Related]
8. Modulating cell state to enhance suspension expansion of human pluripotent stem cells.
Lipsitz YY; Woodford C; Yin T; Hanna JH; Zandstra PW
Proc Natl Acad Sci U S A; 2018 Jun; 115(25):6369-6374. PubMed ID: 29866848
[TBL] [Abstract][Full Text] [Related]
9. Scalable expansion of human-induced pluripotent stem cells in xeno-free microcarriers.
Badenes SM; Fernandes TG; Rodrigues CA; Diogo MM; Cabral JM
Methods Mol Biol; 2015; 1283():23-9. PubMed ID: 25108454
[TBL] [Abstract][Full Text] [Related]
10. Scalable Expansion of Human Pluripotent Stem Cell-Derived Neural Progenitors in Stirred Suspension Bioreactor Under Xeno-free Condition.
Nemati S; Abbasalizadeh S; Baharvand H
Methods Mol Biol; 2016; 1502():143-58. PubMed ID: 26867543
[TBL] [Abstract][Full Text] [Related]
11. Continuous WNT Control Enables Advanced hPSC Cardiac Processing and Prognostic Surface Marker Identification in Chemically Defined Suspension Culture.
Halloin C; Schwanke K; Löbel W; Franke A; Szepes M; Biswanath S; Wunderlich S; Merkert S; Weber N; Osten F; de la Roche J; Polten F; Christoph Wollert K; Kraft T; Fischer M; Martin U; Gruh I; Kempf H; Zweigerdt R
Stem Cell Reports; 2019 Aug; 13(2):366-379. PubMed ID: 31353227
[TBL] [Abstract][Full Text] [Related]
12. Human pluripotent stem cell-derived products: advances towards robust, scalable and cost-effective manufacturing strategies.
Jenkins MJ; Farid SS
Biotechnol J; 2015 Jan; 10(1):83-95. PubMed ID: 25524780
[TBL] [Abstract][Full Text] [Related]
13. Hydrogel-Based Bioprocess for Scalable Manufacturing of Human Pluripotent Stem Cell-Derived Neural Stem Cells.
Lin H; Du Q; Li Q; Wang O; Wang Z; Liu K; Elowsky C; Zhang C; Lei Y
ACS Appl Mater Interfaces; 2018 Sep; 10(35):29238-29250. PubMed ID: 30091584
[TBL] [Abstract][Full Text] [Related]
14. Integrated processes for expansion and differentiation of human pluripotent stem cells in suspended microcarriers cultures.
Lam AT; Chen AK; Ting SQ; Reuveny S; Oh SK
Biochem Biophys Res Commun; 2016 May; 473(3):764-8. PubMed ID: 26385176
[TBL] [Abstract][Full Text] [Related]
15. Scalable ex vivo expansion of human mesenchymal stem/stromal cells in microcarrier-based stirred culture systems.
Carmelo JG; Fernandes-Platzgummer A; Cabral JM; da Silva CL
Methods Mol Biol; 2015; 1283():147-59. PubMed ID: 25063496
[TBL] [Abstract][Full Text] [Related]
16. Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells.
Chen VC; Ye J; Shukla P; Hua G; Chen D; Lin Z; Liu JC; Chai J; Gold J; Wu J; Hsu D; Couture LA
Stem Cell Res; 2015 Sep; 15(2):365-75. PubMed ID: 26318718
[TBL] [Abstract][Full Text] [Related]
17. Production of oncolytic adenovirus and human mesenchymal stem cells in a single-use, Vertical-Wheel bioreactor system: Impact of bioreactor design on performance of microcarrier-based cell culture processes.
Sousa MF; Silva MM; Giroux D; Hashimura Y; Wesselschmidt R; Lee B; Roldão A; Carrondo MJ; Alves PM; Serra M
Biotechnol Prog; 2015; 31(6):1600-12. PubMed ID: 26289142
[TBL] [Abstract][Full Text] [Related]
18. The suspension culture of undifferentiated human pluripotent stem cells using spinner flasks.
Chen VC; Couture LA
Methods Mol Biol; 2015; 1283():13-21. PubMed ID: 25537838
[TBL] [Abstract][Full Text] [Related]
19. Clinical-Grade Manufacturing of Therapeutic Human Mesenchymal Stem/Stromal Cells in Microcarrier-Based Culture Systems.
Fernandes-Platzgummer A; Carmelo JG; da Silva CL; Cabral JM
Methods Mol Biol; 2016; 1416():375-88. PubMed ID: 27236684
[TBL] [Abstract][Full Text] [Related]
20. Human Pluripotent Stem Cell Expansion in Stirred Tank Bioreactors.
Manstein F; Halloin C; Zweigerdt R
Methods Mol Biol; 2019; 1994():79-91. PubMed ID: 31124106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
